Mimedx Group, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
—
13F top-10 QoQ
Top fund weight
Last report0 of 6 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
SentenceEntered into an exclusive U.S. distribution agreement for RegenKit®-Wound Gel with Regen Lab USA, LLC, continuing to broaden the Company's leading Wound product offering beyond placental allografts.
MDXG 10-Kaccession 0001376339-26-000011
SentenceHELIOGEN is manufactured by Regenity Biosciences, a developer and manufacturer of bioresorbable technologies.
MDXG 10-Kaccession 0001376339-26-000011
SentenceFor example, in Japan, our distribution partner, Gunze Medical, purchases products from us and is responsible for sales to the end users for the approved indications of use and at the prevailing reimbursement rate for the product.
MDXG 10-Kaccession 0001376339-26-000011
Mimedx Group, Inc.
3.88
−0.09 · −2.22%
post 3.88 0.00%
Mimedx has 3 disclosed suppliers and 1 disclosed customer in SEC filings.
Expected move
No implied move.